Methods report on the development of the 2013 revision and update of the EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria
Open Access
Abstract
This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU‐funded network of excellence, the Global Allergy and Asthma European Network (GA2LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence‐based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS) and is published in Allergy 2014; 69:868–887.Keywords
This publication has 94 references indexed in Scilit:
- Up‐dosing with bilastine results in improved effectiveness in cold contact urticariaAllergy, 2013
- H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey StudyPLOS ONE, 2011
- Omalizumab is effective in nonautoimmune urticariaJournal of Allergy and Clinical Immunology, 2011
- Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticariaAnnals of Allergy, Asthma & Immunology, 2010
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trialJournal of the American Academy of Dermatology, 2006
- Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool childrenAnnals of Allergy, Asthma & Immunology, 2001
- Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticariaAnnals of Allergy, Asthma & Immunology, 2000
- Double-Blind Multicentre Comparative Study of Ebastine, Terfenadine and Placebo in the Treatment of Chronic Idiopathic Urticaria in AdultsDrugs, 1996
- Oral cyclosporine for severe chronic idiopathic urticaria and angioedemaJournal of the American Academy of Dermatology, 1991